GE Healthcare announced that Clarient Diagnostic Service, Inc., a GE Healthcare company, has made significant upgrades to its fluorescence in situ hybridization (FISH) technologies to improve virtual analysis of testing results for a variety of blood diseases, including leukemia, lymphoma, myelodysplastic syndrome, and myeloma.
The Federal Trade Commission said Friday it has approved Thermo Fisher Scientific Inc.'s $13.6...
Certara announced that Medivir AB, a Swedish pharmaceutical company that focuses on infectious...
Improvements in assay reagents and availability of high-throughput screen (HTS)-compatible readers has made fluorescence lifetime (FLT) technology a cost-effective screening technology. TTP Labtech has consolidated its position in the field with the purchase of assets from AssayMetrics Limited, a FLT company.
Thermo Fisher Scientific announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company, for approximately $1.06 billion.
AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts.
Designed for laboratory research, TECA's high-temperature versions of several cold/hot plate models can heat up to +150 °C.
The HT-4X centrifugal evaporator from Genevac provides sample preparation capabilities for scientists working in the drug discovery environment.
Horizon Discovery has entered into a collaboration agreement with Desktop Genetics for development of a CRISPR design platform. The platform will be used by Horizon to quickly identify the best guide-RNAs in the human genome for each gene editing task, as part of its GENESIS suite of gene-editing technologies.
The MiniSeal II semi-automatic microplate sealer from Porvair Sciences comes complete with adapters enabling it to process deep-well, shallow-well, low-profile deep-well, filter and assay plates that conform to the ANSI/SLAS standard format. Learn more...
ImmunoChemistry Technologies (ICT), a Minnesota-based biotechnology company that supplies unique biochemical laboratory reagents and assay tests to medical researchers, has changed ownership. Now majority women-owned, ICT develops new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans.
Zyoxel has announced preliminary results from a testing by Sanofi on Zyoxel’s LiverChip platform for drug metabolism and pharmacokinetic (DMPK) studies. So for what applications was the platform especially useful in the testing? Find out...
Molecular Devices' next-generation SpectraMax MiniMax 300 imaging cytometer is designed to enable both cellular visualization and stain-free cell-based analysis on the field-upgradable SpectraMax i3 multi-mode microplate reader.
AMS Biotechnology has developed a custom phospho-specific antibody production service that is design to be both reliable and to produce highly specific quality antisera. Learn more...
QIAGEN Announces Third Co-development Program for Companion Diagnostics Paired with Lilly’s Investigational Cancer CompoundsNovember 18, 2013 10:51 am | News | Comments
QIAGEN announced an agreement with Eli Lilly and Company to develop and commercialize a molecular companion diagnostic paired with a novel Lilly oncology compound. This is the third co-development project by QIAGEN and Lilly to create companion diagnostics, which are tests that analyze genomic information in patient samples to enable personalized decisions on treatments.
The IP & Science business of Thomson Reuters and NuMedii have started an initiative to identify new treatments for areas of unmet medical need. How does the partnership propose to systematically identify new applications for existing drug compounds? Find out...
Abcam's new Alexa Fluor 405/568/750 conjugated secondary antibodies to its existing Alexa Fluor 488/555/594/647 conjugates. Extensively tested in Abcam’s labs, the Alexa Fluor range guarantees bright staining and low background. Learn more...
Bio-Rad Laboratories' TGX FastCast acrylamide andTGX Stain-Free FastCast acrylamide kits are designed to provide handcast gel users access to Bio-Rad’s TGX gel chemistry, previously available only in precast gels.
Personal Genome Diagnostics Inc. will collaborate with MolecularMD to market a suite of comprehensive personalized medicine services to oncology researchers and drug developers, adding PGDx’s expertise in next-generation sequencing (NGS)-based cancer biomarker discovery to MolecularMD’s capabilities in the development, validation and global delivery of cancer companion diagnostics. Read more...
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is enabling cancer research with its latest next-generation sequencing (NGS) product, the xGen Acute Myeloid Leukemia Cancer Panel v1.0.
Elsevier today announced that Sanofi has implemented QUOSA’s literature management tools to automate adverse event monitoring. QUOSA powers the retrieval, storage, tagging and annotation of relevant case reports, allowing for the creation of a centralized repository of product-related scientific literature.
Fluxion Biosciences has launched its BioFlux Quattro high-throughput array system for physiologically relevant live cell analysis.
Corning Incorporated's Corning TransportoCells are designed to help accelerate a key step in the drug discovery and development process.
Earlier this month, MPI Research broke ground for a new preclinical imaging center, which will open in spring 2014 in Mattawan, Mich. How will this new facility help advance drug development? Scott Haller, director of the new molecular imaging center, explains.
Sartorius Stedim Biotech (SSB) and BD Diagnostics today announced a collaboration to develop, manufacture and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories. So what will this strategic collaboration specifically involve?
Molecular Devices' ScanLater western blot detection system combines western blot membrane detection with a multimode microplate reader platform, eliminating the need to acquire a separate dedicated western blot system.
Life Technologies Corporation has extended its collaborative agreement with Japanese firm DNAVEC Corporation to launch CytoTune-iPS 2.0 Sendai Reprogramming Kit, the next-generation research technology that enables the most efficient method to develop induced pluripotent stem (iPS) cells from human somatic cells.
Researchers from RayBiotech Inc., in collaboration with scientists from several universities and institutes, have identified five biomarkers present in patient serum which allow for the early detection of ovarian cancer. What technology did the researchers use to make this discovery? Find out...
- Page 1